Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the…
Biorelevant in vitro release models are valuable analytical tools for oral drug development but often tailored to gastrointestinal conditions in ‘average’ healthy adults. However, predicting in vivo performance in individual patients whose…